{"entity":{"type":"insider","cik":"0001881190","url":"/insider/0001881190","json_url":"/insider/0001881190.json","name":"Gheuens Sarah","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":18,"first":"2023-06-30","last":"2026-08-06","span_basis":"filed_date"},"name_variants":[{"name":"Gheuens Sarah","source":"filing","n_filings":18,"first_seen":"2023-06-30","last_seen":"2026-08-06"}],"transactions":[{"id":5905939,"accession":"0001439222-26-000120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-26-000120","line_url":"/filing/0001439222-26-000120#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":30.48,"price_display":"30.48","price_state":"stated","total_value":914400.0,"total_display":"914,400.00","total_whole":"914,400","shares_owned_after":54645.0,"shares_owned_after_display":"54,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-04","filed_date":"2026-08-06","scope":"insider"},{"id":6075609,"accession":"0001439222-26-000110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-26-000110","line_url":"/filing/0001439222-26-000110#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4007.0,"shares_display":"4,007","price_per_share":37.56,"price_display":"37.56","price_state":"stated","total_value":150502.92,"total_display":"150,502.92","total_whole":"150,503","shares_owned_after":84645.0,"shares_owned_after_display":"84,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider"},{"id":5871108,"accession":"0001439222-26-000065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-26-000065","line_url":"/filing/0001439222-26-000065#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2940.0,"shares_display":"2,940","price_per_share":34.71,"price_display":"34.71","price_state":"stated","total_value":102047.4,"total_display":"102,047.40","total_whole":"102,047","shares_owned_after":80277.0,"shares_owned_after_display":"80,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-06","scope":"insider"},{"id":5905938,"accession":"0001439222-26-000040","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001439222-26-000040","line_url":"/filing/0001439222-26-000040","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4055.0,"shares_display":"4,055","price_per_share":28.96,"price_display":"28.96","price_state":"stated","total_value":117432.8,"total_display":"117,432.80","total_whole":"117,433","shares_owned_after":71593.0,"shares_owned_after_display":"71,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider","n_lines":3},{"id":5823715,"accession":"0001439222-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-26-000006","line_url":"/filing/0001439222-26-000006#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2932.0,"shares_display":"2,932","price_per_share":27.09,"price_display":"27.09","price_state":"stated","total_value":79427.88,"total_display":"79,427.88","total_whole":"79,428","shares_owned_after":64795.0,"shares_owned_after_display":"64,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-30","filed_date":"2026-01-02","scope":"insider"},{"id":4596339,"accession":"0001439222-25-000118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000118","line_url":"/filing/0001439222-25-000118#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2454.0,"shares_display":"2,454","price_per_share":43.78,"price_display":"43.78","price_state":"stated","total_value":107436.12,"total_display":"107,436.12","total_whole":"107,436","shares_owned_after":61727.0,"shares_owned_after_display":"61,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-11","filed_date":"2025-11-13","scope":"insider"},{"id":4397358,"accession":"0001881190-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001881190-25-000004","line_url":"/filing/0001881190-25-000004#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":43.81,"price_display":"43.81","price_state":"stated","total_value":8762.0,"total_display":"8,762.00","total_whole":"8,762","shares_owned_after":61727.0,"shares_owned_after_display":"61,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-30","filed_date":"2025-11-03","scope":"insider"},{"id":4925294,"accession":"0001439222-25-000111","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000111","line_url":"/filing/0001439222-25-000111#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3302.0,"shares_display":"3,302","price_per_share":43.92,"price_display":"43.92","price_state":"stated","total_value":145023.84,"total_display":"145,023.84","total_whole":"145,024","shares_owned_after":61727.0,"shares_owned_after_display":"61,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-27","filed_date":"2025-10-29","scope":"insider"},{"id":4399383,"accession":"0001439222-25-000082","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001439222-25-000082","line_url":"/filing/0001439222-25-000082","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11914.0,"shares_display":"11,914","price_per_share":37.98900705052879,"price_display":"37.99","price_state":"stated","total_value":452601.03,"total_display":"452,601.03","total_whole":"452,601","shares_owned_after":62118.0,"shares_owned_after_display":"62,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-09","filed_date":"2025-07-11","scope":"insider","n_lines":2},{"id":4964505,"accession":"0001439222-25-000073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000073","line_url":"/filing/0001439222-25-000073#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4091.0,"shares_display":"4,091","price_per_share":34.17,"price_display":"34.17","price_state":"stated","total_value":139789.47,"total_display":"139,789.47","total_whole":"139,789","shares_owned_after":61271.0,"shares_owned_after_display":"61,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-01","filed_date":"2025-07-03","scope":"insider"},{"id":5212479,"accession":"0001439222-25-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000069","line_url":"/filing/0001439222-25-000069#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2909.0,"shares_display":"2,909","price_per_share":33.54,"price_display":"33.54","price_state":"stated","total_value":97567.86,"total_display":"97,567.86","total_whole":"97,568","shares_owned_after":56988.0,"shares_owned_after_display":"56,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-26","scope":"insider"},{"id":4782230,"accession":"0001439222-25-000013","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001439222-25-000013","line_url":"/filing/0001439222-25-000013","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4005.0,"shares_display":"4,005","price_per_share":35.54,"price_display":"35.54","price_state":"stated","total_value":142337.7,"total_display":"142,337.70","total_whole":"142,338","shares_owned_after":53897.0,"shares_owned_after_display":"53,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider","n_lines":3},{"id":3204762,"accession":"0001439222-24-000111","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000111","line_url":"/filing/0001439222-24-000111#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3705.0,"shares_display":"3,705","price_per_share":43.85,"price_display":"43.85","price_state":"stated","total_value":162464.25,"total_display":"162,464.25","total_whole":"162,464","shares_owned_after":43736.0,"shares_owned_after_display":"43,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider"},{"id":2607031,"accession":"0001439222-24-000054","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-24-000054","line_url":"/filing/0001439222-24-000054","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2642.0,"shares_display":"2,642","price_per_share":32.57,"price_display":"32.57","price_state":"stated","total_value":86049.94,"total_display":"86,049.94","total_whole":"86,050","shares_owned_after":39066.0,"shares_owned_after_display":"39,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-05","scope":"insider","n_lines":2},{"id":2251311,"accession":"0001439222-24-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000030","line_url":"/filing/0001439222-24-000030#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":642.0,"shares_display":"642","price_per_share":25.14,"price_display":"25.14","price_state":"stated","total_value":16139.88,"total_display":"16,139.88","total_whole":"16,140","shares_owned_after":33431.0,"shares_owned_after_display":"33,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-14","filed_date":"2024-02-14","scope":"insider"},{"id":3181915,"accession":"0001439222-24-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000020","line_url":"/filing/0001439222-24-000020#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1708.0,"shares_display":"1,708","price_per_share":21.64,"price_display":"21.64","price_state":"stated","total_value":36961.12,"total_display":"36,961.12","total_whole":"36,961","shares_owned_after":31911.0,"shares_owned_after_display":"31,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-24","scope":"insider"},{"id":2477999,"accession":"0001439222-24-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000004","line_url":"/filing/0001439222-24-000004#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1789.0,"shares_display":"1,789","price_per_share":22.99,"price_display":"22.99","price_state":"stated","total_value":41129.11,"total_display":"41,129.11","total_whole":"41,129","shares_owned_after":27869.0,"shares_owned_after_display":"27,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-09","scope":"insider"},{"id":7846886,"accession":"0001439222-23-000105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000105","line_url":"/filing/0001439222-23-000105#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001881190","owner_name":"Gheuens Sarah","owner_display_name":"Gheuens Sarah","owner_url":"/insider/0001881190","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1707.0,"shares_display":"1,707","price_per_share":28.36,"price_display":"28.36","price_state":"stated","total_value":48410.52,"total_display":"48,410.52","total_whole":"48,411","shares_owned_after":24159.0,"shares_owned_after_display":"24,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-06-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Officer (Chief Medical Officer)","n_filings":18,"first_seen":"2023-06-30","last_seen":"2026-08-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001881190","retrieved_at":"2026-08-25T00:22:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}